Significant Ownership of GILEAD SCIENCES, INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for GILEAD SCIENCES, INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Andrew D. Dickinson - Andrew D. Dickinson, Chief Financial Officer
- Manager location
- Foster City, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow GILEAD SCIENCES, INC. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from GILEAD SCIENCES, INC.
Significant Ownership of GILEAD SCIENCES, INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx, Inc. | Common Stock, par value $0.001 | 100% | $11,482 | -$771,671,118 | 100 | -100% | GILEAD SCIENCES, INC. | 28 Apr 2026 |
| GLPG | Galapagos NV | Ordinary Shares, no par value | 30% | $555,786,955 | 20,981,010 | Gilead Sciences, Inc. | 07 Jan 2025 | ||
| RCUS | Arcus Biosciences, Inc. | Common Stock, par value $0.0001 | 26% | $427,376,736 | 31,424,760 | 0% | GILEAD SCIENCES, INC. | 03 Nov 2025 | |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | Common Stock, par value $0.001 | 25% | 4,977,089 | +10% | GILEAD SCIENCES, INC. | 22 May 2026 | ||
| XLO | Xilio Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 20% | $9,581,667 | +$2,576,464 | 14,517,678 | +37% | GILEAD SCIENCES, INC. | 31 Dec 2025 |
| KLRS | Kalaris Therapeutics, Inc. | Common Stock, $0.0001 per value | 3.9% | $4,715,740 | 723,273 | GILEAD SCIENCES, INC. | 18 Mar 2025 | ||
| IKNA | Ikena Oncology, Inc. | Common Stock | 3.6% | $1,612,591 | 1,521,312 | GILEAD SCIENCES INC | 31 Dec 2024 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | GILEAD SCIENCES, INC. | 31 Dec 2025 |
Schedules 13D/G Reported by GILEAD SCIENCES, INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.